748 related articles for article (PubMed ID: 24379064)
1. The diagnostic value of serum procalcitonin, IL-10 and C-reactive protein in community acquired pneumonia and tuberculosis.
Niu WY; Wan YG; Li MY; Wu ZX; Zhang LG; Wang JX
Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3329-33. PubMed ID: 24379064
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of serum procalcitonin in patients with community-acquired lobar pneumonia.
Lee JY; Hwang SJ; Shim JW; Jung HL; Park MS; Woo HY; Shim JY
Korean J Lab Med; 2010 Aug; 30(4):406-13. PubMed ID: 20805714
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of serum procalcitonin levels in pulmonary tuberculosis.
Ugajin M; Miwa S; Shirai M; Ohba H; Eifuku T; Nakamura H; Suda T; Hayakawa H; Chida K
Eur Respir J; 2011 Feb; 37(2):371-5. PubMed ID: 20530033
[TBL] [Abstract][Full Text] [Related]
4. Role of C-reactive protein and procalcitonin in differentiation of tuberculosis from bacterial community acquired pneumonia.
Kang YA; Kwon SY; Yoon HI; Lee JH; Lee CT
Korean J Intern Med; 2009 Dec; 24(4):337-42. PubMed ID: 19949732
[TBL] [Abstract][Full Text] [Related]
5. Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia.
Schleicher GK; Herbert V; Brink A; Martin S; Maraj R; Galpin JS; Feldman C
Eur Respir J; 2005 Apr; 25(4):688-92. PubMed ID: 15802344
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of C-reactive protein and procalcitonin in suspected community-acquired pneumonia adults visiting emergency department and having a systematic thoracic CT scan.
Le Bel J; Hausfater P; Chenevier-Gobeaux C; Blanc FX; Benjoar M; Ficko C; Ray P; Choquet C; Duval X; Claessens YE;
Crit Care; 2015 Oct; 19():366. PubMed ID: 26472401
[TBL] [Abstract][Full Text] [Related]
7. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis.
Hoshina T; Nanishi E; Kanno S; Nishio H; Kusuhara K; Hara T
J Infect Chemother; 2014 Oct; 20(10):616-20. PubMed ID: 25027057
[TBL] [Abstract][Full Text] [Related]
8. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia.
España PP; Capelastegui A; Mar C; Bilbao A; Quintana JM; Diez R; Esteban C; Bereciartua E; Unanue U; Uranga A
J Infect; 2015 May; 70(5):457-66. PubMed ID: 25499199
[TBL] [Abstract][Full Text] [Related]
9. Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia?
Pereira JM; Teixeira-Pinto A; Basílio C; Sousa-Dias C; Mergulhão P; Paiva JA
J Crit Care; 2013 Dec; 28(6):970-4. PubMed ID: 24216331
[TBL] [Abstract][Full Text] [Related]
10. Serum procalcitonin in pulmonary tuberculosis.
Rasmussen TA; Søgaard OS; Camara C; Andersen PL; Wejse C
Int J Tuberc Lung Dis; 2011 Feb; 15(2):251-6, i. PubMed ID: 21219690
[TBL] [Abstract][Full Text] [Related]
11. Predictive values of semi-quantitative procalcitonin test and common biomarkers for the clinical outcomes of community-acquired pneumonia.
Ugajin M; Yamaki K; Hirasawa N; Yagi T
Respir Care; 2014 Apr; 59(4):564-73. PubMed ID: 24170911
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of C-reactive protein, procalcitonin, and mid-regional pro-atrial natriuretic peptide to guide site of care of community-acquired pneumonia.
Claessens YE; Mathevon T; Kierzek G; Grabar S; Jegou D; Batard E; Loyer C; Davido A; Hausfater P; Robert H; Lavagna-Perez L; Bernot B; Plaisance P; Leroy C; Renaud B
Intensive Care Med; 2010 May; 36(5):799-809. PubMed ID: 20232049
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of blood parameters for community-acquired pneumonia.
Huang Y; Liu A; Liang L; Jiang J; Luo H; Deng W; Lin G; Wu M; Li T; Jiang Y
Int Immunopharmacol; 2018 Nov; 64():10-15. PubMed ID: 30144639
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic value of procalcitonin in community-acquired pneumonia.
Horie M; Ugajin M; Suzuki M; Noguchi S; Tanaka W; Yoshihara H; Kawakami M; Kichikawa Y; Sakamoto Y
Am J Med Sci; 2012 Jan; 343(1):30-5. PubMed ID: 22207498
[TBL] [Abstract][Full Text] [Related]
15. Elevated inflammatory markers combined with positive pneumococcal urinary antigen are a good predictor of pneumococcal community-acquired pneumonia in children.
Galetto-Lacour A; Alcoba G; Posfay-Barbe KM; Cevey-Macherel M; Gehri M; Ochs MM; Brookes RH; Siegrist CA; Gervaix A
Pediatr Infect Dis J; 2013 Nov; 32(11):1175-9. PubMed ID: 23694836
[TBL] [Abstract][Full Text] [Related]
16. Cytokine activation patterns and biomarkers are influenced by microorganisms in community-acquired pneumonia.
Menéndez R; Sahuquillo-Arce JM; Reyes S; Martínez R; Polverino E; Cillóniz C; Córdoba JG; Montull B; Torres A
Chest; 2012 Jun; 141(6):1537-1545. PubMed ID: 22194589
[TBL] [Abstract][Full Text] [Related]
17. Serum procalcitonin as a diagnostic aid in patients with acute bacterial septic arthritis.
Paosong S; Narongroeknawin P; Pakchotanon R; Asavatanabodee P; Chaiamnuay S
Int J Rheum Dis; 2015 Mar; 18(3):352-9. PubMed ID: 25469944
[TBL] [Abstract][Full Text] [Related]
18. Assessment of inflammatory markers in patients with community-acquired pneumonia--influence of antimicrobial pre-treatment: results from the German competence network CAPNETZ.
Krüger S; Ewig S; Kunde J; Hartmann O; Marre R; Suttorp N; Welte T;
Clin Chim Acta; 2010 Dec; 411(23-24):1929-34. PubMed ID: 20699094
[TBL] [Abstract][Full Text] [Related]
19. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children.
Toikka P; Irjala K; Juvén T; Virkki R; Mertsola J; Leinonen M; Ruuskanen O
Pediatr Infect Dis J; 2000 Jul; 19(7):598-602. PubMed ID: 10917215
[TBL] [Abstract][Full Text] [Related]
20. The value of serum procalcitonin in differential diagnosis of pulmonary embolism and community-acquired pneumonia.
Köktürk N; Kanbay A; Bukan N; Ekim N
Clin Appl Thromb Hemost; 2011 Oct; 17(5):519-25. PubMed ID: 20699253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]